Analytiker, investerare och media bjuds in till presentation av RaySearchs delårsrapport för det andra kvartalet 2024 den 16 augusti 2024 kl 10.00. Rapporten publiceras den 16 augusti 2024 kl 07.45 och kommer tillsammans med presentationsbilder att finnas tillgänglig på raysearchlabs.com. Johan Löf, grundare och vd, samt Annika Blondeau Henriksson, interim CFO, kommer att presentera bolagets utveckling i en webcast. Efter presentationen (som hålls på engelska) finns möjlighet att ställa frågor.
Länk till webcast: RaySearch Q2, 2024
About RaySearch
RaySearch Laboratories AB (publ) is a medical technology company that develops innovative software solutions for improved cancer treatment. RaySearch markets the RayStation®* treatment planning system (TPS) and the oncology information system (OIS) RayCare®*. The most recent additions to the RaySearch product line are RayIntelligence® and RayCommand®*. RayIntelligence is an oncology analytics system (OAS) which enables cancer clinics to collect, structure and analyze data. RayCommand, a treatment control system (TCS), is designed to link the treatment machine and the treatment planning and oncology information systems.
RaySearch's software has been sold to over 1,000 clinics in 43 countries. The company was founded in 2000 as a spin-off from the Karolinska Institute in Stockholm and the share has been listed on Nasdaq Stockholm since 2003. More information is available at raysearchlabs.com.
* Subject to regulatory clearance in some markets.
For more information, please contact:
Johan Löf, founder and CEO, RaySearch Laboratories AB (publ)
Telephone: +46 (0) 8 510 530 00
johan.lof@raysearchlabs.com